Planetmed Sp. z o.o.
- Address
- lock Available on a paid plan
Digestive System Diseases
At Planetmed Sp. z o.o. researchers are focusing on conditions of the gastrointestinal tract, aiming to test new therapies that can bring clinical remission and improve quality of life for patients.
- Celiac Disease
- Crohn’s Disease
- Ulcerative Colitis
- Primary Biliary Cholangitis
- Cirrhosis of the liver
The site has launched 26 trials with a team of four investigators, exploring innovative treatments and better diagnostic tools for these digestive disorders.
Immune System Diseases
Studies at this centre evaluate novel agents designed to modulate autoimmune inflammation in diseases such as Crohn’s disease and ulcerative colitis.
- Crohn’s Disease
- Ulcerative Colitis
- Primary Biliary Cholangitis
- Moderately to Severely Active Ulcerative Colitis
- Moderately to Severely Active Crohn’s Disease
Across 26 clinical trials, investigators are assessing the safety and effectiveness of emerging immunomodulators to achieve lasting disease control.
Immune System Phenomena
Research here delves into the underlying immune system mechanisms that drive chronic gut inflammation, seeking biomarkers and therapeutic targets.
- Immune-mediated inflammation in Crohn’s disease
- Immune pathways in ulcerative colitis
- Immune response in primary biliary cholangitis
- Immune system phenotypes in celiac disease
- Immune activation in liver cirrhosis
The 26 ongoing studies involve comprehensive safety monitoring and efficacy assessments to translate immune insights into patient benefit.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 22 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1F. Hoffmann-La Roche AG2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG3trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Planetmed Sp. z o.o.
lock Showing 1 of 28 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1 Study of Afimkibart Effects on Cytochrome P450-Mediated Drug Metabolism in Patients With Active Ulcerative Colitis | F. Hoffmann-La Roche AG | Phase I | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 22 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tulisokibart | 3 | Unknown | 2024-08-20 | 2025-09-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.